<Disease><Name>PEROXISOME BIOGENESIS DISORDER 2B (PBD2B)</Name><Synonym>ADRENOLEUKODYSTROPHY, NEONATAL</Synonym><OMIM><Number>202370</Number><URL>http://omim.org/entry/202370</URL></OMIM><Orphanet><Number>44</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=44</URL></Orphanet><Protein><Number>Peroxisomal targeting signal 1 receptor</Number><URL>http://www.uniprot.org/uniprot/P50542</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>12p13.31</Gene><ICD>E71.3</ICD><Summary>rare (&gt;200 cases) ;autosomal recessive;mutation in the PEX5 gene</Summary><Symptoms><symtomp><id>2365</id><symptom>adrenal atrophy (autopsy)</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2435</id><symptom>adrenal insufficiency</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2367</id><symptom>demyelinisation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1782</id><symptom>epicanthus or medial eyelid fold</symptom><category>EYES</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2218</id><symptom>low set ears</symptom><category>EARS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2368</id><symptom>micropolygyria</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2242</id><symptom>Peroxisomes, liver</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2490</id><symptom>Plasmalogens, biosynthesis</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>2269</id><symptom>prominent forehead / frontal bossing</symptom><category>HEAD</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1593</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>14.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1597</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>4.80</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1677</id><name>Pimelic acid</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1687</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.90</min><max>2.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1717</id><name>Pimelic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>74.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>99</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>555</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>556</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>558</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1441</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>74.00</min><max>610.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2008</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>843</id><name>Alkyl-dihydroxyacetone-phosphate synthase</name><specimen>fibroblasts</specimen><value>increased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1375</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>47.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1374</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>986</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>4.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>437</id><name>C26:0</name><specimen>plasma</specimen><value>increased</value><min>0.45</min><max>1.32</max><unit>&#956;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>786</id><name>C26:0</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.06</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>838</id><name>C26:0</name><specimen>fibroblasts</specimen><value>increased</value><min>0.05</min><max>0.21</max><unit>&#181;g/mg</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>439</id><name>Hexacosenoic acid C26:1</name><specimen>plasma</specimen><value>increased</value><min>0.02</min><max>0.51</max><unit>&#181;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>787</id><name>Hexacosenoic acid C26:1</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>495</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1121</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>837</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>fibroblasts</specimen><value>increased</value><min>3.20</min><max>14.30</max><unit>nmol/2h/mg protein </unit><age>no data</age><method /><comment /></metabolite><metabolite><id>841</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>fibroblasts</specimen><value>increased</value><min>1.60</min><max>3.40</max><unit>nmol/2h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>844</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>platelets</specimen><value>increased</value><min>2.20</min><max>4.90</max><unit>nmol/2h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>884</id><name>Dihydroxycholestanoic acid (DHCA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>885</id><name>Dihydroxycholestanoic acid (DHCA)</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.12</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>840</id><name>Phytanic acid oxidation</name><specimen>fibroblasts</specimen><value>increased</value><min>5.30</min><max>18.80</max><unit>% oxidized</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>436</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.10</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>500</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>881</id><name>Phytanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>433</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>35.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>435</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2036</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>428</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.80</min><max>5.30</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>429</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>3.80</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>430</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.40</min><max>4.90</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>431</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.70</min><max>2.60</max><unit>&#181;mol/l</unit><age>&gt;5 years</age><method /><comment /></metabolite><metabolite><id>432</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>13.90</min><max>44.70</max><unit>&#181;mol/g creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>434</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>13.40</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>842</id><name>Plasmalogens, biosynthesis</name><specimen>fibroblasts</specimen><value>increased</value><min>0.40</min><max>0.80</max><unit>3H/14C</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>792</id><name>Pristanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>880</id><name>Pristanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>nmol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1686</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2037</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1378</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>57.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>95</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>94</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>650</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>651</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>653</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>654</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2039</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/g creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>378</id><name>Suberic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>1.70</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>379</id><name>Suberic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>652</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>10.10</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>886</id><name>Trihydroxycholestanoic acid (THCA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>887</id><name>Trihydroxycholestanoic acid (THCA)</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.03</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4902</id><title>Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders</title><author>Klouwer FC,</author><journal>Neuropediatrics</journal><year>2016</year><book /><volume>47</volume><number>4</number><pages>205-220</pages><co_aut>et al.</co_aut></literature><literature><id>3152</id><title>Neonatal adrenoleukodystrophy: a clinical, pathologic, and biochemical study</title><author>Farrell DF</author><journal>Pediatr Neurol</journal><year>2012</year><book /><volume>47</volume><number>5</number><pages>330-336</pages><co_aut /></literature><literature><id>4901</id><title>Genetics and molecular basis of human peroxisome biogenesis disorders</title><author>Waterham HR,</author><journal>Biochim Biophys Acta</journal><year>2012</year><book /><volume>1822</volume><number>9</number><pages>1430-1441</pages><co_aut>Ebberink MS</co_aut></literature><literature><id>2857</id><title>Neonatal adrenoleukodystrophy presenting with seizure at birth: a case report and review of the literature</title><author>Chang YC</author><journal>Pediatr Neurol</journal><year>2008</year><book /><volume>38</volume><number>2</number><pages>137-139</pages><co_aut>et al.</co_aut></literature><literature><id>1412</id><title>Novel mutations in the PEX2 gene of four unrelated patients with a peroxisome biogenesis disorder</title><author>Gootjes J</author><journal>Pediatr Res</journal><year>2004</year><book /><volume>55</volume><number>3</number><pages>431-436</pages><co_aut>et al.</co_aut></literature><literature><id>1413</id><title>Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder</title><author>Gootjes J</author><journal>Eur J Hum Genet</journal><year>2004</year><book /><volume>12</volume><number>2</number><pages>115-120</pages><co_aut>et al.</co_aut></literature><literature><id>1591</id><title>Peroxisomal localization in the developing mouse cerebellum: implications for neuronal abnormalities related to deficiencies in</title><author>Nagase T</author><journal>Biochim Biophys Acta</journal><year>2004</year><book /><volume>1671</volume><number>0</number><pages>26-33</pages><co_aut>et al.</co_aut></literature><literature><id>1415</id><title>Pharmacological induction of redundant genes for a therapy of X-ALD: phenylbutyrate and other compounds</title><author>Bugaut M</author><journal>Adv Exp Med Biol</journal><year>2003</year><book /><volume>544</volume><number>0</number><pages>281-291</pages><co_aut>et al.</co_aut></literature><literature><id>1414</id><title>Pharmacological induction of peroxisomes in peroxisome biogenesis disorders</title><author>Wei H</author><journal>Ann Neurol</journal><year>2000</year><book /><volume>47</volume><number>3</number><pages>286-296</pages><co_aut>et al.</co_aut></literature><literature><id>982</id><title>Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29000 controls</title><author>Moser AB</author><journal>Ann Neurol</journal><year>1999</year><book /><volume>45</volume><number>1</number><pages>100-110</pages><co_aut>et al.</co_aut></literature><literature><id>116</id><title>Disorders of peroxisome biogenesis</title><author>Lazarow PB</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>71</number><pages>2287-2324</pages><co_aut>Moser HW</co_aut></literature><literature><id>229</id><title>Peroxisomal disorders</title><author>Heymans HS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>0</volume><number>0</number><pages>421-433</pages><co_aut>Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature><literature><id>231</id><title>Clinical and biochemical characteristics of peroxisomal disorders: un update</title><author>Wanders RJA</author><journal>Eur J Pediatr Suppl</journal><year>1994</year><book /><volume>153</volume><number>0</number><pages>S44-S48</pages><co_aut>Barth PG, Schutgens RBH, Tager JM</co_aut></literature><literature><id>51</id><title>Peroxysomal Disorders: Concentrations of metabolites in cerebrospinal fluid compared wth plasma</title><author>Ten Brink HJ</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>587-589</pages><co_aut>van den Heuvel CMM, Poll-The BT, Wanders RJA, Jacobs C</co_aut></literature><literature><id>842</id><title>Docosahexaenoic acid - a new therapeutic approach to peroxisomal-disorder patients: experience with two cases</title><author>Martinez M</author><journal>Neurology</journal><year>1993</year><book /><volume>43</volume><number>0</number><pages>1389-1397</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>